A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer.
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Non-small Cell Lung Cancer|Non-Hodgkins Lymphoma
Interventions: DRUG: Vinorelbine Tartrate
Sponsor: Mast Therapeutics, Inc.
Collaborators: Synteract, Inc.|Thywill Latam Solutions SRL|OCASA Soluciones Logísticas S.A.|Worldwide Clinical Trials